Hogan Lovells Cadwalader has advised Jazz Pharmaceuticals. Cooley has advised Actio Biosciences. Paul Hastings has advised funds managed by Deerfield Management Company L.P., in their capacity...
Jazz Pharmaceuticals Announces $820 Million Acquisition of Actio Biosciences
Oak Hill Bio and RACC Announce $175 Million Business Combination to Form Nasdaq-Listed Rare Disease Company
Wilson Sonsini Goodrich & Rosati has advised Oak Hill Bio on IP matters. Cooley has advised Research Alliance Corporation III (RACC). OHB Pediatrics Ltd., operating as...
UCB to Acquire Candid Therapeutics in $2.2 Billion Deal
Cooley and Wilson Sonsini Goodrich & Rosati have advised Candid Therapeutics. Covington & Burling has represented UCB. UCB, a global biopharmaceutical company, has announced a definitive...
K5 Global Leads $2.25 Billion Acquisition of Majority Stake in HistoSonics
Orrick has advised K5 Global. Fox Rothschild has advised HistoSonics. Cooley has advised a syndicate of investors including K5 Global, Bezos Expeditions, Wellington Management, and others....
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...